Diabetologia 54 , S317 (2011)
Pharmacotherapy (2011) 31:896911
J Clin Microbiol 47 , 17261732, (2009)
KPV, a short melanocortin-related fragment, is commonly investigated for its interaction with inflammatory pathways
3 Note that this consensus algorithm is a guide and that the clinical management of T2DM should always incorporate the patients unique goals, comorbidities, individual response to therapy, and other factors that may introduce unwanted drug interactions or contraindications to a particular therapy or therapies
Moreover, GHS peptides are currently a banned doping agent in professional sports, and little is known about their long-term safety